Healthy living concerns such as obesity and eating healthy foods top the list of health issues for B.C. children aged 10 to 16 years old, according to a report presented to Health Minister George Abbott today by Child Health BC at the conclusion of the one-year public input into the Conversation on Health.
The provincial government is enhancing food safety in British Columbia with a new meat inspection regulation that takes effect on Sept. 30, 2007, and will also provide support to processors to complete facility upgrades with a temporary transitional licence.
The U.S. Food and Drug Administration announced the approval of Lamisil Oral Granules for the treatment of tinea capitis, a fungal infection of the scalp, in children ages 4 years and older.
Sabanero Inc. is voluntarily recalling FOR FRYING and GRATING Cheese 5.5 pounds loafs with lot number 177, expiration date of October_22/07 made by COOPERATIVA COLANTA in their San Pedro Plant in Colombia South America.
Topps Meat Company LLC., located in Elizabeth, NJ, has voluntarily expanded its recall announced on September_25 to include 21.7 million pounds of ground beef products that may be contaminated with E. coli O157:H7.
The U.S. Food and Drug Administration approved Afluria, an additional seasonal influenza vaccine for the immunization of people ages 18 and older. Afluria is intended to protect adults from influenza type A and type B flu viruses. Influenza is a contagious respiratory illness that can cause annual epidemics.
The U.S. Food and Drug Administration announced its intention to take enforcement action against companies marketing unapproved prescription drug products containing hydrocodone, a narcotic widely used to treat pain and suppress coughs. The action does not affect other hydrocodone formulations, which have FDA approval.
Highly pathogenic H7N3 avian influenza has been detected in a commercial poultry operation in Saskatchewan, the Canadian Food Inspection Agency (CFIA) announced. This virus is not the same as the strain circulating in Asia, Africa and Europe, which has been associated with human illness.
The Oxford Health Alliance (OxHA), a global coalition with the aim of preventing the epidemic of chronic disease, is launching a groundbreaking public health research programme to enhance scientific knowledge about the effectiveness of community interventions in reducing the prevalence of chronic diseases.
GlaxoSmithKline (NYSE: GSK)announced that it will join with other pharmaceutical companies, academic institutions and the U.S. Food and Drug Administration to research genetic markers that may help predict who is at risk for serious drug-related adverse events.